Literature DB >> 19847154

In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

Bruce A Perkins1, Linda H Ficociello, Bijan Roshan, James H Warram, Andrzej S Krolewski.   

Abstract

We sought to study new-onset microalbuminuria, its progression, and the decline of renal function in patients with type 1 diabetes. Using a cohort of 109 patients who developed new-onset microalbuminuria in the first 4 years following enrollment in the 1st Joslin Kidney Study, we simultaneously tracked the change in their renal function and urinary albumin excretion. Of these, 79 patients were followed for an average of 12 years after microalbuminuria onset, wherein their glomerular filtration rate was estimated by the Modification of Diet in Renal Disease Study formula and compared with their microalbuminuria and proteinuria. The concordance between these outcomes was weak. Only 12 of the 23 patients who progressed to advanced (stage 3-5) chronic kidney disease developed proteinuria, which, in general, did not precede but accompanied the progression to advanced chronic kidney disease. The remaining 11 patients who developed advanced disease had persistent microalbuminuria or returned to normal albuminuria. Thus, we found that one-third of patients with type 1 diabetes developed advanced chronic kidney disease relatively soon after the onset of microalbuminuria and this was not conditional on the presence of proteinuria. Contrary to the existing concept of early nephropathy in type 1 diabetes, less emphasis should be placed on the mechanisms of progression to proteinuria and more placed on mechanisms initiating and promoting the early decline of renal function that eventually progresses to advanced chronic kidney disease.

Entities:  

Mesh:

Year:  2010        PMID: 19847154      PMCID: PMC3725722          DOI: 10.1038/ki.2009.399

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  41 in total

1.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

2.  Longitudinal studies on the rate of decline in renal function with age.

Authors:  R D Lindeman; J Tobin; N W Shock
Journal:  J Am Geriatr Soc       Date:  1985-04       Impact factor: 5.562

3.  Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion.

Authors:  H H Parving; B Oxenbøll; P A Svendsen; J S Christiansen; A R Andersen
Journal:  Acta Endocrinol (Copenh)       Date:  1982-08

4.  Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion.

Authors:  P H Lane; M W Steffes; S M Mauer
Journal:  Diabetes       Date:  1992-05       Impact factor: 9.461

5.  Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus.

Authors:  G Biesenbach; O Janko; J Zazgornik
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

6.  Progressive decline in renal function in diabetic patients with and without albuminuria.

Authors:  C Tsalamandris; T J Allen; R E Gilbert; A Sinha; S Panagiotopoulos; M E Cooper; G Jerums
Journal:  Diabetes       Date:  1994-05       Impact factor: 9.461

7.  Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Authors:  Johannes F E Mann; Roland E Schmieder; Matthew McQueen; Leanne Dyal; Helmut Schumacher; Janice Pogue; Xingyu Wang; Aldo Maggioni; Andrzej Budaj; Suphachai Chaithiraphan; Kenneth Dickstein; Matyas Keltai; Kaj Metsärinne; Ali Oto; Alexander Parkhomenko; Leopoldo S Piegas; Tage L Svendsen; Koon K Teo; Salim Yusuf
Journal:  Lancet       Date:  2008-08-16       Impact factor: 79.321

8.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

9.  Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus.

Authors:  K Zeller; E Whittaker; L Sullivan; P Raskin; H R Jacobson
Journal:  N Engl J Med       Date:  1991-01-10       Impact factor: 91.245

10.  Monitoring glomerular function in diabetic nephropathy. A prospective study.

Authors:  G C Viberti; R W Bilous; D Mackintosh; H Keen
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

View more
  104 in total

1.  Early renal function decline in type 2 diabetes.

Authors:  Meda E Pavkov; William C Knowler; Kevin V Lemley; Clinton C Mason; Bryan D Myers; Robert G Nelson
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Diabetes: hyperfiltration-a risk factor for nephropathy in T1DM?

Authors:  Christos Chatzikyrkou; Hermann Haller
Journal:  Nat Rev Endocrinol       Date:  2012-04-24       Impact factor: 43.330

3.  Diabetic nephropathy: Aldosterone breakthrough in patients on an ACEI.

Authors:  Takahiko Nakagawa
Journal:  Nat Rev Nephrol       Date:  2010-04       Impact factor: 28.314

Review 4.  Anti-fibrosis therapy and diabetic nephropathy.

Authors:  Anil Karihaloo
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 5.  Time to re-evaluate effects of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in diabetic nephropathy.

Authors:  Hiromichi Suzuki; Tomohiro Kikuta; Tsutomu Inoue; Ukihiro Hamada
Journal:  World J Nephrol       Date:  2015-02-06

6.  Hypertension: Is there a dark side to thiazide therapy for hypertension?

Authors:  Takahiko Nakagawa; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2010-10       Impact factor: 28.314

7.  Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Authors:  Justyna Siwy; Joost P Schanstra; Angel Argiles; Stephan J L Bakker; Joachim Beige; Petr Boucek; Korbinian Brand; Christian Delles; Flore Duranton; Beatriz Fernandez-Fernandez; Marie-Luise Jankowski; Mohammad Al Khatib; Thomas Kunt; Maria Lajer; Ralf Lichtinghagen; Morten Lindhardt; David M Maahs; Harald Mischak; William Mullen; Gerjan Navis; Marina Noutsou; Alberto Ortiz; Frederik Persson; John R Petrie; Johannes M Roob; Peter Rossing; Piero Ruggenenti; Ivan Rychlik; Andreas L Serra; Janet Snell-Bergeon; Goce Spasovski; Olivera Stojceva-Taneva; Matias Trillini; Heiko von der Leyen; Brigitte M Winklhofer-Roob; Petra Zürbig; Joachim Jankowski
Journal:  Nephrol Dial Transplant       Date:  2014-03-02       Impact factor: 5.992

8.  Silent diabetic nephropathy.

Authors:  Katia López-Revuelta; Patricia Peña Galdo; Ramona Stanescu; Leticia Parejo; Carmen Guerrero; Elia Pérez-Fernández
Journal:  World J Nephrol       Date:  2014-02-06

Review 9.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25

Review 10.  Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes.

Authors:  Andrzej S Krolewski; Tomohito Gohda; Monika A Niewczas
Journal:  Clin Exp Nephrol       Date:  2013-11-12       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.